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Abstract A set of physicochemical properties describing
a protein of known structure is employed for a calibrative
approach to protein solubility. Common hydrodynamic and
electrophoretic properties routinely measured in the bio-
analytical laboratory such as zeta potential, dipole moment,
the second osmotic virial coefﬁcient are ﬁrst estimated in
silico as a function a pH and solution ionic strength starting
with the protein crystal structure. The utility of these
descriptors in understanding the solubility of a series of
ribonuclease Sa mutants is investigated. A simple two
parameter model was trained using solubility data of the
wild type protein measured at a restricted number of
solution pHs. Solubility estimates of the mutants demon-
strate that zeta potential and dipole moment may be used to
rationalize solubility trends over a wide pH range. Addi-
tionally a calibrative model based on the protein’s second
osmotic virial coefﬁcient, B22 was developed. A modiﬁed
DVLO type potential along with a simpliﬁed representation
of the protein allowed for efﬁcient computation of the
second viral coefﬁcient. The standard error of prediction
for both models was on the order of 0.3 log S units. These
results are very encouraging and demonstrate that these
models may be trained with a small number of samples and
employed extrapolatively for estimating mutant solubil-
ities.
Keywords Protein solubility   Second osmotic virial  
Calibration   Zeta potential
Introduction
In many protein engineering applications one seeks to
optimize or control the physical chemical properties of a
protein under a given set of conditions. For protein thera-
peutics, often site directed mutagenesis studies are done to
ﬁnd mutants that have similar activity but have enhanced
solubility or solution stability. To a crystallographer, cre-
ating mutant series can help optimize protein crystalliza-
tion conditions thereby eliminating conditions or mutations
that do not lead to optimal crystal growth. Often this work
is carried out empirically and can lead to unexpected
results. A more rational approach, however simple, would
immensely help guide the researcher toward their goal.
Bioanalytical laboratories routinely quantitate basic
parameters such as size, zeta potential, isoelectric point, the
second osmotic virial (B22) and dipole moment. These key
parameters aid the understanding of the behavior of col-
loidal suspensions and proteins. For certain formulations
such as injectable drugs one may want to maximize the
repulsive forces between particles. This ensures that the
suspension does not settle or lead to caking. Alternatively
one may want to separate a protein from the mother liquor
by minimizing the repulsive forces between particles
allowing for efﬁcient ﬂocculation.
The electrostatic properties of a protein play a large role
in solution solubility. These properties are governed both
by the protein charge distribution and by the nature of the
solvent in the formation of the electric double layer. The
double layer arises from the presence of surface charges on
the protein and its inﬂuence on ions at the protein-solvent
interface. This results in an increased concentration of ions
of opposite charge (counter-ions) near charged surface
regions. As one moves further away from the surface, the
ion distribution eventually becomes homogeneous as in the
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or attenuate surface charges felt further out in solution.
Because of these effects, the inner layer of solvent mole-
cules and counter ions surrounding the protein are tightly
bound and move in concert. Furthermore there exists an
equilibrium distance at which there is a balance between
ions that are held by electrostatic forces and those that
sheared away due to Brownian motion. This characteristic
distance is known as the Debye screening length [1]. This
length, j
-1, is typically on the order of tens of A ˚ngstroms
and depends on the concentration and properties of dis-
solved salts in solution. At the Debye length these forces
may be quantiﬁed as measurable electric potential. Theo-
retically the zeta potential is the average potential, uðrÞ at
the solvation boundary. In the laboratory the zeta potential
is determined either by optical means [2] or through elec-
trophoretic band velocity measurements. In its simplest
form, the zeta potential, f, is related to the electrophoretic
velocity, U through the following equation:
U ¼
ef
g
E ð1Þ
where g is the solution viscosity, e is the dielectric constant
and E is the strength of the applied ﬁeld. A variety of
techniques also exist for estimating f from a molecular
simulation. Typically these involve the use of the Poisson–
Boltzmann (PB) equation [1]. For proteins, boundary
integral approaches [3] to solving the PB equation or non-
equilibrium molecular dynamics [4] may be used. As
practical a rule of thumb, if the measured zeta potential lies
within ?30 mV to -30 mV this would be indicative of
colloidal instability. In this range surface charges on the
protein are simply not strong enough for effective protein–
protein repulsion.
The second osmotic virial coefﬁcient is also routinely
measured electro-optically in the laboratory. This thermo-
dynamic property arises as a higher order term in the
equation governing osmotic pressure,
P ¼ RTcP
1
MW
þ B22cP þ ...
  
ð2Þ
where P is the osmotic pressure, cP is the protein
concentration, R is the gas constant, T is the absolute
temperature and MW is the protein molecular weight. The
second virial coefﬁcient B22 indicates the magnitude and
direction ofthe deviations from solution idealityand may be
thoughtofastheeffectivevolumeoftheprotein.Thisshould
not be interpreted as a hard sphere volume but one that is
inﬂuenced by protein–protein electrostatic interactions. By
measuring B22 at various solution conditions one can gain
insight about the underlying effective pair interactions
between proteins. A positive value may be interpreted to
reﬂectrepulsiveinteractionswhereasanegativevaluewould
indicate the presence of attractive forces. Statistical
mechanics also provides a mathematical relationship
between the B22 and the potential of mean force, U,i na n
average solvent environment [5]
B22 ¼
1
2MWqV
Z
X1
Z
X2
Z 1
0
ð1   e U=kTÞr2
12dr12dX1dX2 ð3Þ
where q is the density of the protein, V is its volume, k is
the Boltzmann constant and r12 is the intermolecular cen-
ter-to-center distance. For an isotropic sphere, the integral
may be interpreted as a Boltzmann weighted volume.
However where there is non-uniform charge distribution, it
may be more appropriate to think of this as a Boltzmann
average over all protein–protein conﬁgurations (X1, X2).
The portion of the integral corresponding to an overlap
where U ? ? leads to the excluded volume contribution
of the virial coefﬁcient [6].
When estimating B22, often an idealized protein geom-
etry is assumed. Protein molecules are typically treated as
uniform spheres with a ﬁxed charge. Although these sim-
plistic models can provide some insight, they may not be
reliable near the protein’s isoelectric point i.e. when z, the
net charge, is zero. If classical DLVO theory [7, 8] were
to serve as the electrostatic potential energy function, then
the potential U, and thus B22, would be zero. However if
charge anisotropy were taken into account, then conﬁgu-
rations that lead to energetically favorable interactions
between proteins would bias the Boltzmann weighting
term in Eq. 3 toward a negative B22. This would indicate
protein that would have a higher tendency to agglomerate
than what would otherwise be predicted by an isotropic
model.
A number of years ago it was shown by George and
Wilson that there is a strong correlation between the
measured B22 and the range of solution conditions that
favor protein crystallization [9, 10]. The crystallization
success rate was highest if B22 falls within a well deﬁned
range of -1 9 10
-4 to -8 9 10
-4 mol mL g
-2.I fB22 is
too large, crystallization rates are slowed due to the dom-
inating repulsive interactions. Conversely if B22 is too
small, amorphous aggregation can result. It was pointed out
that this ‘‘crystallization window’’ corresponds closely to
the necessary conditions for the presence of a liquid–liquid
immiscibility region in a phase diagram [11, 12]. Further,
this region may indicate nucleation via a liquid–liquid
phase separation as a ﬁrst step is a favorable mechanism for
crystal growth [12, 13].
Other research efforts have focused on ﬁnding a relation
between B22 and protein solubility in aqueous solutions
[13–16]. Finding such a trend is not unexpected as both
solubility and the second virial coefﬁcient are governed to
a large degree by interactions between protein molecules.
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solubility is a function of the protein–protein binding
energy at speciﬁc orientation in the crystal whereas B22 is a
statistical quantity relating protein–protein interactions in
solution over all distance and orientations [13]. The theo-
retical relation developed by Haas and Wilson has been
shown to be in excellent agreement with experimental data
for lysozyme and holds over a range solvent pHs, tem-
perature and salt concentrations where the second virial
coefﬁcient would be expected to apply [13]. However other
studies have shown non-monotonic variation of B22 with
salt concentration [14]. At high salt concentrations, so
called ‘‘salting-in’’ and ‘‘salting-out’’ effects are poorly
modeled within the standard DLVO or non-linear Poisson
Boltzmann framework.
In this study, our goal is to explore the use of calibrative
models of protein solubility at a ﬁxed salt concentration.
Such models may prove to be of high value to biochemists
who seek insight into which point mutations and pH con-
ditions optimize solubility. In this work we use a crystal
structure to provide the necessary information about a
protein’s three dimensional charge distribution, although a
homology model could be used. Additionally we will
explore the possibility of employing a modiﬁed DVLO
theory that can account for non-isotropic charge distribu-
tion in a protein. These ideas will be tested on a series of
mutants of Ribonuclease Sa, a well characterized protein
for which published solubility data exists [17, 18].
Methods
A protein properties calculator has recently been developed
in the Molecular Operating Environment (MOE) [19]. This
tool allows one to process one or more proteins, create
mutations, and compute a series of protein-speciﬁc descrip-
tors. The user can specify the working temperature, pH,
solvent dielectric and viscosity and the concentration and
nature of the dissolved binary salt. A series of 19 descriptors
areoutput.Theserangefrombasicsize,eccentricity,volume,
and surface area descriptors to electrostatic and transport
properties. Most of these properties may be quantiﬁed in an
analytical laboratory using light scattering, ultracentrifuga-
tionandelectrophoretictechniques.Althoughalldescriptors
were computed only the critical ones actually used in the
models are discussed in detail below.
Protein preparation and charge model
Prior to computing the protein descriptors, partial charges
were ﬁrst assigned to all atoms using the AMBER 99
forceﬁeld. If one or more point mutations needed to be
made, the appropriate residues sidechains were exchanged
and minimized keeping atom coordinates of all other res-
idues ﬁxed.
For the purposes of determining the protein’s isoelectric
point (pI), routines were used that identify titratable groups
within the structure and estimate their pKa values based on
the PROPKA method [20]. Given pKa estimates for each
titratible residue, the Sillero and Ribeiro method was then
used to estimate the pI of the protein [21]. As this pI
estimate is based on pKa values determined from local 3D
residue geometries, it will be referred to as pI3D. For
comparison, estimates of pI were also made using ﬁxed
group pKa values. This pI estimate will be referred to as
pIseq. The group pKa values used originate from a recent
review [22] of 78 folded proteins (His: 6.6, Lys: 10.5, Arg:
12.3, Asp: 3.5, Glu: 4.2, Cys: 6.8, Tyr: 10.3).
Charges on individual residues were set with the use of
the Henderson-Hasselbalch equation [23] given their esti-
mated pKa values. This ensured a zero net charge at the
isoelectric point and allowed for smooth transitions as the
pH is varied. It is recognized that charges set in this manner
are only appropriate for relative comparisons of similar
proteins and are not suitable for molecular mechanical
minimizations.
It should also be noted out that in a study of confor-
mational stability of these same proteins [17], the pH of
maximum stability for each protein lies near pH 5. The
conformational stability measured as a free energy dropped
by approximately 50% from its peak value by either raising
or lowering the solution pH by 3 units. In light of this, care
must be taken when interpreting the physical signiﬁcance
of the descriptors under conditions that may denature or
affect the ionization state of the protein.
Zeta potential estimates
From the Gouy-Chapman-Stern model the f potential of a
charged particle may be determined by estimating the
electrostatic potential at the slipping plane in the diffuse
layer. It is recognized that although the position of this
plane somewhat dependent on the mathematical model and
on particle size [24], in this study we are primarily con-
sidered with relative changes in f potential. We therefore
simply assume that this surface is situated at one Debye
length, j
-1 away from the protein. This characteristic
distance is typically on the order of tens of A ˚ngstroms and
depends on the ionic strength of dissolved salts in solution,
the permittivity of free space, e0, and the dielectric constant
er as well as the absolute temperature, T:
j 1 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
e0erkT
2NAe2I
r
: ð4Þ
The other constants in Eq. 4 are Avogadro’s number,
NA, the Boltzmann constant, k, and the charge on
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deﬁned as
I ¼
1
2
X
i
z2
i mi ð5Þ
where m is the mass concentration of the ith ionic species
and z its valency. For a protein with an inhomogeneous
distribution of charges, the electrostatic potential ﬁeld,
uðrÞ was estimated from a numerical solution of the
linearized Poisson–Boltzmann equation. In this study the
interior and exterior dielectric constants were ﬁxed at 4 and
78 respectively. The Poisson–Boltzmann equation was
solved numerically with the multi-grid preconditioned
conjugate residual algorithm in MOE on a (129)
3 grid.
The grid was constructed so that it encompassed the entire
protein and extended one Debye length plus and additional
buffer in each Cartesian direction away from the protein’s
extremities. This ensured a convergent solution over a wide
range of solution conditions. The f potential was then
computed by integrating the potential, uðrÞ over the
solvation boundary:
f hi¼
1
Aj
Z
Vj
uðrÞdA ð6Þ
where Vj deﬁnes a set of points encompassing the protein
and solvation layer and Aj is its surface area.
Dipole moment
The dipole moment of the protein was computed from
Eq. 6 at a given pH-appropriate protonation state:
l ¼ 4:802
X N
i
qiri ð7Þ
where qi is the partial charge of ith atom and ri is the
distance in A ˚ from the center of mass. The multiplicative
factor was used to convert the dipole moment to units of
Debye. AMBER 99 charges calculated in MOE were used
as the charge model.
Second virial coefﬁcient, B22
The interaction energies between two proteins were sam-
pled using a 5-axis z-x–z Eulerian gimbal system. This
allows one to test any relative conﬁguration. Each protein
may be separated by a distance, r12, rotated by an arbitrary
longitudinal and azimuthal angle (a, b for protein 1 and h,
u for protein 2), and rotated by a relative twist angle, c). As
for the potential model used to compute the interaction
energies, a variety of forms are typically used and is still
the subject of much discussion [6, 13, 14, 16, 25]. However
in a study comparing square-well to Yukawa potentials it
was concluded that the relation between the solubility and
the second virial coefﬁcient depended very little on the
shape of the interaction potential [13]. In light of this, we
developed a potential model that was easy to compute
using the existing machinery in MOE. Toward this end, the
electrostatic component of the interaction energy was
computed using the following formula,
Uel ¼
e2
4pe0er
X
i
X
j
qiqj
rij
ð8Þ
where i and j are atom indices for proteins 1 and 2 respec-
tively, q is the partial charge on a given atom and rij is the
relative distance between atoms i and j. Unfortunately Eq. 8
does not account for inter-particle charge screening effects
due the presence of dissolved salts in the medium. In order
to account for this, numerical solutions of the Poisson
Boltzmann equation would be normally be required for all
conﬁgurations. However such an approach would simply be
too time prohibitive. There exists however a linearized
solution to the Poisson Boltzmann equation for two spheres
of radius a with uniform surface change z0 placed in a dielec-
tric medium separated by a distance r12.T h i sa p p r o x i m a t i o n
is the framework of Derjaguin, Landau, Verwey and Over-
beek (DLVO) theory [7, 8]. The electrostatic component of
this classical theory is,
UDLVOðr12Þ¼
ðz0eÞ
2
4pe0er
expð2jaÞ
ð1 þ jaÞ
2
expð jr12Þ
r12
: ð9Þ
If a system of two particles both having a charge z0 are
considered, then by inspection it may be seen that Eq. 9
closely resembles Eq. 8 multiplied by a scaling factor that
accounts for dielectric screening. For large separation
distances, r12,E q .8 may be modiﬁed to:
Uðr12Þ 
e2
4pe0er
expð2jaÞ expð jr12Þ
ð1 þ jaÞ
2
X
i
X
j
qiqj
rij
ð10Þ
This approximation will serve as the electrostatic model.
For small distances (r12 B a) inside the exclusion volume,
a hard sphere potential will be used.
Additionally there exists several forms of the multipli-
cative constant outside of the conﬁguration integral in
Eq. 3 [6, 13, 14]. In general this factor depends on protein
molecular weight, density and volume and a normalization
constant. Since we will employ a calibrative approach to
estimating the solubility from B22, we are less concerned
this factor and allow it to be a free parameter, a, in our
model. We leave the divisor 2MWqV in place to account for
the units and to ensure proper scaling. The Boltzmann
volumetric weighting factor in Eq. 3 also presents a chal-
lenge when one encounters either a very favorable (quasi-
docked) protein–protein conﬁguration or a low energy
sample not in the training set. Because of this we employ a
910 J Comput Aided Mol Des (2010) 24:907–916
123modiﬁed potential bUr ðÞ cU 0 hi ½  where U0 hi is an esti-
mate of the average minimum interaction energy over all
samples under consideration and b and c are free scaling
factors. The minimum interaction energy U0 hi is needed
especially when dealing with protein solutions that are not
inﬁnitely dilute or when solving Eq. 3 numerically. At a
typical working protein concentrations for crystallization
(*15 mg mL
-1), the average maximum protein–protein
separation distance is on the order of 115 A ˚ and gives a
rough indication of the required upper limit of integration
along r12. Although interaction energies beyond this point
may be non-zero, they will not contribute signiﬁcantly to
the Boltzmann average. We therefore choose cU 0 hi as our
reference point. For our modiﬁed potential, the scaling
factors b and c can be seen to account for discrepancies
between the theoretical and actual exclusion volume,
solution conditions and choice of energy scale. The func-
tional form of B22 becomes:
B22 ¼
a
2MWqV
Z
X1
Z
X2
Z 1
0
ð1   e bðU cU0Þ=kTÞr2
12dr12dX1dX2:
ð11Þ
Continuing toward our ultimate goal of relating the
second virial to solubility a survey of the literature has
revealed a few thermodynamical and empirical forms [13,
15, 16]. An equation developed by Haas et al. provides us
with a mathematically stable functional form for the ﬁtting
procedure [12]. Writing the solubility in terms of B22 we
use the following equation:
S ¼ 55:55MW
1   qMWB22=4
d
þ 1
    N=2
ð12Þ
where d is a parameter which depends on the anisotropy,
N is the coordination number and S is the solubility in
mg mL
-1. Typically N is between 3 and 6 and d is on the
order of 0.001. The coordination number is reported to be
related to be number of nearest neighbor protein molecules
in the crystal.
Finally given a set of experimental solubilities, condi-
tions and a crystal structure for the training compounds,
and an estimate of U0 hi , we ﬁt the optimal parameters in
Eqs. 11 and 12 that minimize ðlogS   log ^ SÞ
2 where ^ S is
the estimated solubility. Non-linear optimization functions
in MOE based on the steepest decent method were used to
perform the ﬁtting.
Reduced protein representation
With a fully atomistic representation of the protein, the
time required to evaluate a large number interaction ener-
gies makes the above computation of B22 impractical.
Although there are many ways to reduce computation
times, a convenient solution was found by replacing the
atoms of each amino acid residue with two that preserve
the net residue charge and the residue dipole moment. In
this reduced representation, two ‘‘atoms’’ were placed at
the centers of negative and positive charge respectively.
The radius a, of this reduced representation was taken to be
that of a sphere that minimally encompassed the reduced
set of atoms plus a small buffer. With this approach, the
protein’s net charge and higher moments are retained.
Additionally the potential energy machinery in MOE could
be employed without modiﬁcation.
Modeling
The crystal structure of Ribonuclease Sa (PDB code:
1RGG) was submitted to the protein properties calculator.
Descriptors were computed at the pH values shown in
Fig. 1 for the wild type, 3K (D17K ? E41K ? D1K), and
5K (D17K ? E41K ? D1K ? D25K ? E74K) mutants.
The dielectric medium was speciﬁed to be a 10 mM NaCl
solution at 298 K. The solvent viscosity was set to that of
water, 0.89 cP. For the intermediate calculations required
to estimate B22, a total of 351,000 protein–protein conﬁg-
urations were sampled. This is comprised of 26 separation
distances from 0 to 104 A ˚, and 30 evenly sampled sets of
azimuthal and longitudinal angles for each protein and 15
twist angles. A total computation time of 14 h was required
for the 24 samples on a 1.8 GHz Intel dual core system.
After the descriptor calculation was complete, a ﬁtting
procedure using experimental solubilities from the training
Fig. 1 Measured solubilities as a function of pH for RNase Sa
(circles), 3K (squares) and 5K variants (triangles). The lines are
meant as a guide only. This ﬁgure is reconstructed from Ref. [13]
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estimates of B22 and log ^ S for all samples. For these cal-
culations, we assumed a density of 1.36 g cm
-3 for the
protein.
Additional pI values were estimated for the 2K
(D17K ? E41K) and 4K (D17K ? E41K ? D1K ? D25K)
variants for comparison with experimental values.
Results and discussion
A set of protein descriptors was computed using the protein
properties calculator for Ribonuclease Sa and four lysine
mutants at solution pHs where published pI and solubility
data exists [17]. The wild type protein contains 96 residues,
has a pI of 3.5 and contains no Lys residues. A set of
variants was created by replacing highly exposed surface
Asp and Glu residues with Lys. This is of interest given
that the natural substrate for the ribonucleases is negatively
charged, the net charge on the enzyme might inﬂuence its
steady-state kinetics [17]. As shown in Table 1, the iso-
electric points for the 2K, 3K, 4K and 5K variants show an
increasing shift toward higher pH. The estimated isoelec-
tric points, pIseq and pI3D, are based respectively on ﬁxed
group pKas and those determined from local 3D residue
geometries. With this small sample, the average error
between the estimated and experimental values is 0.66 pH
units for pIseq and 0.45 pH units for pI3D. In this set, the pI
estimate of the 5K variant appears to have the largest error
of approximately 1 pH unit. This may be due to the fact
that RNase Sa has eight Tyr that are largely buried having
experimental pKa values greater than 11. This is much
higher than the pKa of 10 that is assumed in the calculation
of pIseq. However with most theoretical determinations of
pI, is it a given that the results are accurate to within
±1 pH unit of the experimental value [17, 26]. Although
these estimates based on pI3D look very encouraging for
this set, we have not yet performed any larger scale studies
validating the method and have used these estimates simply
to set the point of zero change for charge based descriptors.
The protein properties calculator also returns pKa esti-
mates of the individual ionizable amino acids given their
relative 3D environment in a protein using the PROKPA
method. Estimates for RNase Sa and its 5K variant are
listed in Table 2 along with of their respective measured
values [27]. For this system the pKas may be estimated to
within ± 1 pH unit of the measured value. It is interesting
to note that that the pKa estimates for each ionizable group
are almost identical between the wild type and the modeled
5K variant. Only the pKa of Glu78 was found to decrease
by 0.1 pH unit. However a different picture emerged when
the group pKa estimates were made on the known crystal
structure of the 5K variant (PDB code 3A5E). In this case
the estimated pKas of eight residues were different.
In order to understand the difference between these
modeled 5K variant and its known crystal structure, two
types of alignments were performed. The ﬁrst was an
alignment on the backbone alpha carbons. Since there was
only a the 0.37 A ˚ RMSD between the two structures, it may
be concluded that the surface mutations do not inﬂuence the
overall protein structure. When the second alignment was
done using the heavy atoms of the ﬁve lysine sidechains,
the RMSD was found to be 1.9 A ˚. Given that the level of
variation, the scoring function employed in PROPKA used
to shift the pKa from its baseline value seems quite sensitive
to sidechain conﬁguration. This scoring function attempts to
account for desolvation, hydrogen bonding and buried
charge–charge interactions [20]. Since there is such a dif-
ference in the predicted shift in pKa between the modeled
5K mutant and the known crystal structure, this would
indicate that the surface lysines in the model are not
forming as many hydrogen bonds with nearby residues.
This is in fact observed by inspection. In light of this result,
it may be better to ﬁrst perform a short molecular dynamics
run on the sidechain atoms in order to generate an ensemble
of conformers then compute a Boltzmann-weighted average
of the predicted group pKas. The only drawback to this
approach is the lengthy computation time.
Solubility modeling with simple electrostatic
descriptors
For an initial model, data from the wild type and 3K variant
served as the training set. The remainder from the 5K
variant served as the test set used for model assessment.
This calibration set was chosen to cover the entire dynamic
range of solubilities. An initial study was done to deter-
mine which of the 19 descriptors were correlated with the
experimentally available solubility values in the training
set. For the charge based descriptors z (net charge) and f
(zeta potential), their square values were used. This was
done because, to a ﬁrst approximation, the solubility of a
protein is known to be proportional to the square of the net
change on the protein [28]. The characteristic parabolic
shape shown in the solubility proﬁles in Fig. 1 clearly
Table 1 Isoelectric points of RNase Sa and the 2K, 3K, 4K and 5K
variants
RNase Sa variant Experimental pI pIseq pI3D
Wild type 3.5 3.9 3.5
2K 4.6 4.8 4.5
3K 6.4 6.2 6.6
4K 8.4 7.1 8.0
5K 10.2 8.4 9.3
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near their isoelectric points and their solubility increases
when either the pH is raised or lowered. Furthermore the
descriptor values were autoscaled to avoid biasing and the
log of the solubility (log S) was used throughout.
Working with the 17 data points in the training set, a
stepwise multi-linear regression procedure was used for
variable selection [29]. With this procedure candidate
variables are included in the model one by one. This pro-
cess continues until successive models are deemed not to
be statistically by means of an F-test at the 95% conﬁdence
level. Using this method it was found that f
2 and l (dipole
moment) were most correlated to log S. It is interesting to
note that although z
2 is also correlated to log S (r
2 = 0.77),
it was not selected with the stepwise procedure given that
f
2 is slightly more correlated (r
2 = 0.83). It was also found
that after removing two of the 3K samples (at pH 5.4 and
5.7) the standard error of prediction for the training set
decreased signiﬁcantly from 0.24 to 0.15. We therefore
constructed our models without them. This leads to a
simple relation which will be referred to a Model 1:
log S = 2.50 ? 0.00274f
2 - 0.00266l (r
2 = 0.968, R
2 =
0.937). As shown in Fig. 2, a plot of experimental
log S versus estimated log S for the calibration set dem-
onstrates that the residues are homoscedastically distrib-
uted about the line of identity.
A more informative view of the results demonstrating
the accuracy of the model is shown in Fig. 3. Here the
estimated and experimental solubilities are plotted as a
function of pH. The standard error of prediction on the test
set (seven 5K samples) was 0.393. Results indicate that the
model reproduces the characteristic parabolic trend in
solubility about the pI in the wild type and shows a mini-
mum point with the 3K and 5K variants. The model also
reproduces the non-linear progression in solubility as the
number of positively charged Lys groups is increased.
However the point of minimum solubility for the 3K var-
iant predicted by the model is shifted 0.5 pH units lower
than what appears experimentally but remains close to the
observed pI. From the reported experimental conditions
[17] it should be noted that the buffer composition is varied
according to the pH which may lead to some uncertainty as
where the true minimum solubility actually lies. The
Table 2 pKa values for RNase
Sa and its 5K mutant
Residue RNase Sa
measured
RNase Sa
estimated
5K variant
measured
5K model
estimated
5K crystal
estimated
Asp01 3.44 2.6 Lys Lys Lys
Asp17 3.72 3.9 Lys Lys Lys
Asp25 4.87 3.8 Lys Lys Lys
Asp33 2.39 1.5 2.12 1.5 2.1
Asp79 7.37 5.2 6.06 5.2 5.1
Asp84 3.01 1.1 2.98 1.1 1.1
Asp93 3.09 2.4 3.00 2.4 2.4
Glu14 5.02 4.1 2.83 4.1 4.1
Glu41 4.14 4.5 Lys Lys Lys
Glu54 3.42 2.5 2.26 2.5 4.2
Glu74 3.47 4.5 Lys Lys Lys
Glu78 3.13 2.9 3.02 2.8 2.6
His53 8.27 6.3 7.39 6.3 7.2
His85 6.35 7.0 6.09 7.0 6.4
Tyr30 11.3 10.1 n.d. 10.1 10.0
Tyr49 10.6 10.0 n.d. 10.0 9.9
Tyr 51,52,55,80,81,86 [11.5 11.3 (avg) n d. 11.3 (avg) 11.3 (avg)
Fig. 2 Plot of the measured versus estimated log S on the training
set. A line of identity is plotted along the diagonal
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123conclusions that may drawn however are clear: the 3K
variant is predicted to be less soluble than the wild type and
the 5K slightly more soluble that the wild type at their
respective isoelectric points. In spite of these results there
exists a fundamental problem as the chemist would need
training data that is likely to cover the full dynamic range
of solubilities ensuring the model be used in an interpola-
tive manner. This calibrative procedure has little utility
since the chemist might only have solubility data of the
wild type and wants to know in advance if it is worth
expressing and testing a given mutant!
A more realistic approach to solubility modeling would
be to train the model using data from a single protein and
employ it in an extrapolative sense to estimate solubilities
of similar proteins at a desired pH. Toward this goal, the
above process was repeated using ﬁve calibration points
from the wild type. A two parameter model based on f
2
and l lead to the following regression equation (Model
2): log S = 2.68 ? 0.00246f
2 - 0.002805l (r
2 = 0.9985,
R
2 = 0.9971, SEP = 0.33). The solubilities of the wild type
are estimated very well as is shown in Fig. 4, however for
the 3K and 5K variants, only the broad trends are cap-
tured. It is interesting to note that even with much fewer
training points, the calibration coefﬁcients for Model 1
and Model 2 are similar. This type of model is more error
prone but more realistic in how it would be used. In this
case, the chemist would get a semi-quantitative picture
that around their respective isoelectric points, the 3K is
less soluble than the wild type and the 5K is slightly more
soluble.
Physical interpretation of solubility models based
on simple electrostatic descriptors
Plots of the estimated zeta potential and dipole moments as
a function of pH are shown in Figs. 5 and 6 respectively.
The zeta potential plot is a type protein titration curve with
f playing the role of an indicator. This may be used to
approximate the isoelectric point (pI)—the point where the
electrophoretic mobility is zero. If the protein were an
isotropic charged sphere of radius a, then at the pI both the
net charge and f would be zero. This condition arises
naturally from the solution of the Poisson Boltzmann
equation for an isotropic sphere as z ¼ 4pe0að1 þ jaÞf=e.
If this relation holds more generally, then one can make
comparisons between protein solutions over a range of pHs
at same ionic strength. With this in mind, it may be seen
from Fig. 5 that pI of the mutant series generally increases
with the number of Lys groups. Additionally, the slopes of
the linear regions near the pI for the wild type and 3K
variants protein give an indication of the steepness of their
corresponding parabolic shaped solubility curves in Fig. 1.
This is because the protein’s relative solubility is typically
proportional to square of the net charge. However for the
5K variant, at 2 pH units lower than the pI there is a
gradual download slope in f whereas the wlope is more
pronounced at 2 pH units higher than the pI. In this case
one would expect a non-symmetric trend in solubility about
the pI which is indeed observed.
A plot of the estimated protein dipole moments as a
function of pH shown in Fig. 6 demonstrates a different set
of trends. In this case the curve shapes of the wild type and
variants are similar but the magnitude of the dipole
Fig. 3 Plot of the measured and estimated log S as a function of pH.
Estimated values were determined from Model 1. Training data from
the wild type and 3K variant is shown as crosses. Experimental
solubilities in the test set (5K variant) are shown as triangles.
Estimated values are shown with lines
Fig. 4 Plot of the measured and estimated log S as a function of pH.
Estimated values were determined from Model 2. Training set data is
shown as crosses. Experimental solubilities belonging to the test set
are shown as either circles (wild type), squares (3K variant) or
triangles (5K variant). Estimated values are shown with lines
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123moment mirrors the trend in solubility at their respective
pIs. It should be mentioned that since we are concerned with
relative changes in dipole moment for a mutant ladder
series, the use AMBER 99 charges is sufﬁcient. For abso-
lute measures of dipole moment other charge models may
be more appropriate [30]. Generally a larger dipole moment
represents greater separation of charge resulting in a more
polarized system. This may lead to increased protein–
protein interactions by attraction of oppositely charged
regions. When this occurs solubility may decrease due to
ﬂocculation.
Solubility modeling with the second osmotic virial
A solubility model based on the expression for the second
osmotic virial (Eq. 11) together with a functional form
relating it to solubility (Eq. 12) was also developed. A
reduced protein conﬁguration was used in the sampling
351,000 interaction energies needed for the conﬁgurational
integral at the heart of the B22 estimate.
Model training was also made using samples from the
wild type. One of the issues encountered when allowing
each parameter a, b, c, d and N to vary is that more training
data was required. Even using all available samples, it was
found that the d and N parameters were too interdependent
to allow for rapid convergence. In studies with lysozyme, it
is reported [13] that a good ﬁt between experimental data
and Eq. 12 was obtained for d = 0.01 and N = 4. In the
absence of any a priori B22 data to suggest otherwise, we
held d and N ﬁxed at these values. Therefore Eq. 12 simply
serves as a generic mapping function relating B22 to the
solubility. The ﬁtting process was done with the same ﬁve
calibration points from the wild type as used previously.
The best ﬁt parameters a, b and c values were found to
be -0.166, 0.23 and 0.136 respectively and the standard
error of prediction was 0.201. The results for Model 3
shown in Fig. 7 demonstrate that the model captures the
broad trends in solubility in the test set. The solubilities of
the wild type are again determined quite well, and the
overall trends in solubility for the 3K and 5K are as good as
those predicted in Model 2. Using the best ﬁt a, b and
c values, one may estimate which proteins/conditions fall
into crystallization window i.e. the range where B22 is
between -1 9 10
-4 and -8 9 10
-4 mol mL g
-2.I ti s
recognized however that since we employed a ﬁxed, gen-
eric mapping function relating B22 to the solubility, the
corresponding ‘‘solubility window’’ is rather approximate.
The use of experimental B22 data however may be used to
Fig. 5 Plot of the estimated zeta potential as a function of pH for the
wild type, 3K and 5K variants
Fig. 6 Plot of the estimated dipole moment as a function of pH for
the wild type, 3K and 5K variants
Fig. 7 Plot of the measured and estimated log S as a function of pH.
Estimated values were determined from Model 3. Training set data is
shown as crosses. Experimental solubilities belonging to the test set
are shown as either circles (wild type), squares (3K variant) or
triangles (5K variant). Estimated values are shown with lines
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123set more appropriate values for d and N. The solubility
window shown in Fig. 7 suggests that the wild type and 5K
variants might have a greatest chance of being crystallized
at ±1 pH units on either side of their respective isoelectric
points. However the 3K variant appears to be too insoluble
under the current solution conditions.
Additionally, preliminary tests were performed by
allowing d vary between 0.01 and 0.035 and N from 3 to 4.
As no signiﬁcant change in the error of prediction was
found in this range, the values of the ﬁtting parameters a,
b and c adjusted to compensate for imprecise knowledge of
d and N. This indicates that one might not need to explicitly
include d and N in the ﬁtting procedure as they are rela-
tively insensitive. From a practical standpoint this may be
advantageous as fewer calibration samples would be
required leaving only the need to pick from amongst a
small set of pre-determined generic mapping functions that
best suits a given protein family.
Conclusions
In this study we have developed simple calibrative
approaches to estimating protein solubility as a function of
pH using a set of descriptors calculated from its 3D
structure. The models are purely electrostatics-based and
other factors that may affect solubility such as hydrophobic
interactions and salting out at high salt concentration are
not accounted for. However even with this limitation,
solubility models may be still be constructed when esti-
mates for a mutant series are sought. A solubility model of
Ribonuclease Sa based on zeta potential and dipole
moment trained on wild type data only demonstrate this.
Additionally the approach allows one to rationalize solu-
bility trends. Another solubility model based on the second
virial coefﬁcient also provides information of interest to
crystallographers who wish to determine whether a given
mutant may likely have a chance of being crystallized.
These results are encouraging given that the models are
extrapolative, based on a range of different theories and
trained on experimental data that is not highly accurate by
its nature. The protein descriptors employed in this work
may be computed very efﬁciently and can provide the
analyst with estimates of critical parameters that take
much longer to determine experimentally. In the future we
wish to extent the methods to non-globular proteins and
investigate the effect of amino acid side chain conforma-
tion on model stability.
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